Chemed Corp
NYSE:CHE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Chemed Corp
Stock-Based Compensation
Chemed Corp
Stock-Based Compensation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Chemed Corp
NYSE:CHE
|
Stock-Based Compensation
$32.7m
|
CAGR 3-Years
8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
16%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Stock-Based Compensation
$88m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
5%
|
|
|
CVS Health Corp
NYSE:CVS
|
Stock-Based Compensation
$535m
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
Cigna Corp
NYSE:CI
|
Stock-Based Compensation
$291m
|
CAGR 3-Years
3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
10%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Stock-Based Compensation
$125.8m
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Stock-Based Compensation
$166.2m
|
CAGR 3-Years
21%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Chemed Corp
Glance View
Chemed Corporation, a somewhat enigmatic yet resolutely steadfast entity, operates in the realms of hospice care and plumbing services, a duality that intrigues analysts and investors alike. Established through strategic foresight, Chemed has crafted a remarkably resilient business model by housing two distinct subsidiaries under its corporate umbrella: VITAS Healthcare and Roto-Rooter. VITAS Healthcare, which still stands as the nation's largest provider of end-of-life care, dominates the hospice sector by offering comprehensive palliative care services right at the patients' doorstep, aiming to ensure dignity and comfort during life's final stages. This subsidiary capitalizes on a combination of Medicare and Medicaid reimbursements as well as private insurances, which form the backbone of its revenue stream. Meanwhile, Roto-Rooter, a company with a name synonymous with plumbing repair and maintenance, fortifies Chemed's revenue streams through an entirely different channel. Known as a household name across America, Roto-Rooter offers an extensive range of services from emergency plumbing repair to water cleanup and restoration. With its franchise model combined with company-operated branches, Roto-Rooter generates income primarily through service fees. The dual nature of Chemed’s operational style—a blend of healthcare sensitivity and industrial pragmatism—not only ensures diversified income avenues but also exemplifies a pragmatic approach to risk management. This business strategy, deftly combining distinct yet robust sectors, allows Chemed to weather economic fluctuations that might impact one industry but not the other, ultimately creating a stable financial foundation for the company.
See Also
What is Chemed Corp's Stock-Based Compensation?
Stock-Based Compensation
32.7m
USD
Based on the financial report for Dec 31, 2025, Chemed Corp's Stock-Based Compensation amounts to 32.7m USD.
What is Chemed Corp's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 10Y
16%
Over the last year, the Stock-Based Compensation growth was 2%. The average annual Stock-Based Compensation growth rates for Chemed Corp have been 8% over the past three years , 12% over the past five years , and 16% over the past ten years .